The co-founder of biotech giant Amgen, Rathmann was the Thousand Oaks firm's first chief executive, overseeing the development of blockbuster drugs to boost growth of red and white blood cells. The firm now has a market value of $54 billion. He was 84. Full obituary
Comments are filtered for language and registration is required. The Times makes no guarantee of comments' factual accuracy. Readers may report inappropriate comments by clicking the Report Abuse link next to a comment. Here are the full legal terms you agree to by using this comment form.